{"article":{"annotation":{"article_id":"canada-health-product-authorizations-q3-2026","available_at":"2026-10-16T16:20:36.543365Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"5e92b61235936df03265bf91e72645216cd61ea66c602734b29c7195e05e141a","input_sha256":"2dfb9d034a593e439a50b5017769dc40bf6b773d9e0fe42c31cbb7216921aed3","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"CA","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html"]}],"geometry":null,"id":"iso3166-1:CA","kind":"country-or-area","labels":{"ar":"كندا","en":"Canada","es":"Canadá","fr":"Canada"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:07000000","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: Health","source_urls":["https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html"]}],"method":"controlled-rules-v1","rule_id":"health","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=es","category":"health","content":{"key_points":[],"paragraphs":["Health Canada informó que autorizó 16 nuevos medicamentos con receta, 33 genéricos o biosimilares y 540 dispositivos médicos nuevos entre el 1 de julio y el 30 de septiembre de 2026. En su actualización trimestral del 15 de octubre, también señaló la presión sobre las revisiones de medicamentos por el aumento de solicitudes cada vez más complejas.","El departamento da prioridad a algunas solicitudes de genéricos y avanza en la modernización de las normas de ensayos clínicos. Una propuesta para medicamentos destinados a niños y jóvenes reduciría los plazos de revisión de 300 a 180 días; seguía en consulta hasta el 23 de octubre y aún no era una norma definitiva."],"sections":[]},"corrections":[],"country":"CA","data":{"blocks":[{"description":{"ar":"أعداد الأدوية والأجهزة الطبية المرخصة من 1 يوليو إلى 30 سبتمبر 2026.","de":"Zahl der vom 1. Juli bis 30. September 2026 zugelassenen Arzneimittel und Medizinprodukte.","en":"Counts of drugs and medical devices authorized from July 1 through September 30, 2026.","es":"Número de medicamentos y dispositivos médicos autorizados del 1 de julio al 30 de septiembre de 2026.","fr":"Nombre de médicaments et de dispositifs médicaux autorisés du 1er juillet au 30 septembre 2026.","pt":"Número de medicamentos e dispositivos médicos autorizados de 1 de julho a 30 de setembro de 2026.","tr":"1 Temmuz–30 Eylül 2026 arasında onaylanan ilaç ve tıbbi cihaz sayıları."},"id":"canada-health-product-authorizations-q3-2026","items":[{"basis":"observed","label":{"ar":"أدوية موصوفة جديدة","de":"Neue verschreibungspflichtige Arzneimittel","en":"New prescription drugs","es":"Nuevos medicamentos con receta","fr":"Nouveaux médicaments sur ordonnance","pt":"Novos medicamentos sujeitos a receita","tr":"Yeni reçeteli ilaçlar"},"measure":{"aggregation":"cumulative","frequency":"quarterly","geography":"canada","id":"canada-new-prescription-drug-authorizations-2026-q3","periodRole":"reference-period","unitCode":"count"},"period":"2026-09","unit":"count","value":16},{"basis":"observed","label":{"ar":"الأدوية الجنيسة والبدائل الحيوية","de":"Generika und Biosimilars","en":"Generic and biosimilar drugs","es":"Medicamentos genéricos y biosimilares","fr":"Médicaments génériques et biosimilaires","pt":"Medicamentos genéricos e biossimilares","tr":"Jenerik ve biyobenzer ilaçlar"},"measure":{"aggregation":"cumulative","frequency":"quarterly","geography":"canada","id":"canada-generic-biosimilar-drug-authorizations-2026-q3","periodRole":"reference-period","unitCode":"count"},"period":"2026-09","unit":"count","value":33},{"basis":"observed","label":{"ar":"أجهزة طبية جديدة","de":"Neue Medizinprodukte","en":"New medical devices","es":"Nuevos dispositivos médicos","fr":"Nouveaux dispositifs médicaux","pt":"Novos dispositivos médicos","tr":"Yeni tıbbi cihazlar"},"measure":{"aggregation":"cumulative","frequency":"quarterly","geography":"canada","id":"canada-medical-device-authorizations-2026-q3","periodRole":"reference-period","unitCode":"count"},"period":"2026-09","unit":"count","value":540}],"methodology":{"ar":"أُخذت الأعداد من البيان الفصلي لوزارة الصحة الكندية المؤرخ 15 أكتوبر 2026؛ وتُعرض الفئات الواردة في المصدر فقط.","de":"Die Zahlen stammen aus der Quartalsmitteilung von Health Canada vom 15. Oktober 2026; dargestellt werden nur die dort genannten Kategorien.","en":"Counts are taken from Health Canada’s quarterly release dated October 15, 2026; only categories stated in the source are shown.","es":"Los recuentos proceden del comunicado trimestral de Health Canada del 15 de octubre de 2026; solo se muestran las categorías indicadas en la fuente.","fr":"Les nombres proviennent du communiqué trimestriel de Santé Canada daté du 15 octobre 2026; seules les catégories indiquées par la source sont présentées.","pt":"As contagens provêm do comunicado trimestral da Health Canada de 15 de outubro de 2026; são apresentadas apenas as categorias indicadas na fonte.","tr":"Sayım, Health Canada'nın 15 Ekim 2026 tarihli üç aylık açıklamasından alınmıştır; yalnızca kaynakta belirtilen kategoriler gösterilir."},"sourceUrls":["https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html"],"title":{"ar":"تراخيص وزارة الصحة الكندية في الربع الثالث من 2026","de":"Zulassungen von Health Canada im dritten Quartal 2026","en":"Health Canada Q3 2026 authorizations","es":"Autorizaciones de Health Canada en el T3 de 2026","fr":"Autorisations de Santé Canada au T3 2026","pt":"Autorizações da Health Canada no terceiro trimestre de 2026","tr":"Health Canada Q3 2026 yetkilendirmeleri"},"type":"metrics","updatedAt":"2026-10-16T15:49:08Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026/data/canada-health-product-authorizations-q3-2026?lang=es&format=csv","json":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026/data/canada-health-product-authorizations-q3-2026?lang=es&format=json"},"id":"canada-health-product-authorizations-q3-2026"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Ilustración conceptual de salud pública, investigación y datos conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-6ab1799d-dd58-5779-b460-49c93284da84","event_period":"2026-09","event_period_basis":"event-or-reference-period","id":"canada-health-product-authorizations-q3-2026","image":null,"importance":0.6,"language":"es","modified_at":"2026-10-16T16:20:29+00:00","publication_basis":"publication-record","published_at":"2026-10-16T16:20:29+00:00","reading_minutes":1,"region":"world","section_illustration":{"alt":"Ilustración conceptual de salud pública, investigación y datos conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"canada-health-product-authorizations-q3-2026","sources":[{"checkedAt":"2026-10-16","name":"Health Canada","publishedAt":"2026-10-15","url":"https://www.canada.ca/en/health-canada/news/2026/10/safe-and-effective-health-products-for-canadians-new-authorizations-between-july-and-september-2026.html"}],"summary":"También autorizó 33 medicamentos genéricos o biosimilares de julio a septiembre y propuso reducir las revisiones de medicamentos pediátricos.","text":"También autorizó 33 medicamentos genéricos o biosimilares de julio a septiembre y propuso reducir las revisiones de medicamentos pediátricos.\n\nHealth Canada informó que autorizó 16 nuevos medicamentos con receta, 33 genéricos o biosimilares y 540 dispositivos médicos nuevos entre el 1 de julio y el 30 de septiembre de 2026. En su actualización trimestral del 15 de octubre, también señaló la presión sobre las revisiones de medicamentos por el aumento de solicitudes cada vez más complejas.\n\nEl departamento da prioridad a algunas solicitudes de genéricos y avanza en la modernización de las normas de ensayos clínicos. Una propuesta para medicamentos destinados a niños y jóvenes reduciría los plazos de revisión de 300 a 180 días; seguía en consulta hasta el 23 de octubre y aún no era una norma definitiva.","title":"Health Canada autorizó 16 nuevos medicamentos con receta y 540 dispositivos en el T3","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=en","language":"en","url":"https://newsverum.com/en/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=es","language":"es","url":"https://newsverum.com/es/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=de","language":"de","url":"https://newsverum.com/de/news/canada-health-product-authorizations-q3-2026"},{"api_url":"https://newsverum.com/api/v1/articles/canada-health-product-authorizations-q3-2026?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/canada-health-product-authorizations-q3-2026"}],"url":"https://newsverum.com/es/news/canada-health-product-authorizations-q3-2026"},"version":"1"}